No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with ustekinumab

P Rodríguez‐Jiménez, P Chicharro… - British Journal of …, 2017 - academic.oup.com
DEAR EDITOR, Ustekinumab is a human monoclonal antibody directed against the p40
subunit of both interleukin (IL)-12 and IL-23. 1 It has been shown to be very effective in …
被引用次数：6 相关文章

[引用][C] No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with ustekinumab

P Rodríguez‐Jiménez, P Chicharro, A Godoy… - British Journal of …, 2017 - cir.nii.ac.jp
No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with
ustekinumab | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

[引用][C] No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with ustekinumab.

P Rodríguez-Jiménez, P Chicharro… - The British Journal of …, 2017 - europepmc.org
No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis
with ustekinumab. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

[引用][C] No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with ustekinumab

P Rodríguez-Jiménez, P Chicharro… - The British journal …, 2017 - pubmed.ncbi.nlm.nih.gov
No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with
ustekinumab No evidence for induction of autoantibodies or autoimmunity during treatment of …

[引用][C] No evidence for induction of autoantibodies or autoimmunity during treatment of psoriasis with ustekinumab

P Rodríguez‐Jiménez, P Chicharro… - British Journal of …, 2017 - Wiley Online Library
Funding sources: this study was partially supported by Instituto de Salud Carlos III (FIS PI
14/01751 & PIE 13/0051), Spanish Ministry of Economy and Competitiveness. No …